REMINDER: Department of Infection, Immunity & Cardiovascular Disease Seminar – Thursday 20th July 2017

Title: “Dysregulated Endothelial Signals in Pulmonary Arterial Hypertension” Speaker: Professor Hyung J. Chun, Yale School of Medicinyomama. Time: 12:30pm – 1:30pm Venue: Lecture Theatre 3, F Floor Medical School. Abstract: The research program of the Chun Lab at Yale University focuses on dysregulated endothelial signalling that contribute to vascular disease processes such as pulmonary arterial…

Continue reading →

MRI method detects progression of lung disease in children with Cystic Fibrosis before normal clinic

Researchers from POLARIS and clinical colleagues from Sheffield Children’s Hospital have shown that using a technique called ‘hyperpolarised gas MRI’, it is possible to measure the progression of lung disease in children with cystic fibrosis (CF), before the normal clinical tests can detect this progression. Hyperpolarised gas MRI requires the participant to breathe in a…

Continue reading →

A new study identifies genes involved in white blood cell biology

An MRC funded project led by researchers in Infection, Immunity and Cardiovascular Disease has culminated in a publication in the journal, Blood, which identifies genes that regulate leukocyte production and function. Neutrophils, our most abundant leukocyte, are critical in fighting infection and responding to inflammation. Defects in neutrophil production and function can lead to devastating…

Continue reading →

Wellcome Trust Clinical Career Development Fellowship awarded to Dr Alex Rothman

Dr Alex Rothman (from the Department of Infection, Immunity & Cardiovascular Disease) has been awarded a Wellcome Clinical Career Development Fellowship to pursue his aim to establish SMURF-1 inhibition as a novel anti proliferative therapy in pulmonary arterial hypertension. Alex will spend time undertaking his research in Sheffield, Cambridge and at Novartis in Boston, Massachusetts,…

Continue reading →